A synergistic interaction of 17βestradiol with specific cannabinoid receptor type 2 antagonist/inverse agonist on proliferation activity in primary human osteoblasts

Author：        

Publisher： Science Publishers

ISSN： 2049-9434

Source： Biomedical Reports, Vol.3, Iss.4, 2015-01, pp. : 554-558

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proteaseactivated receptor 2 agonist increases cell proliferation and invasion of human pancreatic cancer cells

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 1, 2015-01 ,pp. : 239-244

Spandidos Publications

Access to resources Recommend Favorite

Identification of a proliferatoractivated receptor-γ antagonist for the treatment of type 2 diabetes mellitus

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 2, 2015-01 ,pp. : 446-450

Spandidos Publications

Access to resources Recommend Favorite

H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells

By Radvány Z.   Darvas Z.   Kerekes K.   Prechl J.   Szalai C.   Pállinger E.   Valéria L.   Lia Varga V.   Sandor M.   Erdei A.   Falus A.  

Seminars in Cancer Biology, Vol. 10, Iss. 1, 2000-02 ,pp. : 41-45

Academic Press

Access to resources Recommend Favorite

New Perspective Therapy of Breast Cancer Based on Selective Dopamine Receptor D2 Agonist and Antagonist Effects on MCF-7 Cell Line

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 10, Iss. 2, 2015-05 ,pp. : 214-223

Bentham Science Publishers

Access to resources Recommend Favorite

The effects of fulvestrant, an estrogen receptor antagonist, on the proliferation, differentiation and mineralization of osteoprecursor cells

By  

Molecular Medicine Reports, Vol. 7, Iss. 2, 2013-01 ,pp. : 555-558

Spandidos Publications

Access to resources Recommend Favorite